I
Iterum Therapeutics
2 followers
Iterum Therapeutics Limited is dedicated to developing significantly differentiated anti-infectives aimed at combatting MDR pathogens.
Org chart
Corey N. Fishman
Collapse
Judith M. Matthews
Chief Financial Officer
Tom Loughman
SVP, Technical Operations
Louise Barrett
SVP, Legal Affairs
Steven I. Aronin
SVP & Head of Clinical Development
Candida Lionetti
Project Manager
Board & advisors
Ronald M. Hunt
Chairman
Mark Chin
Director
Michael Dunne
Director
Beth P. Hecht
Director
David G. Kelly
Director